As South Korea seeks to foster the biohealth industry through various strategies including creating new markets, the Korea Health Industry Development Institute (KHIDI) is also making broad efforts in its role as a state-funded agency at the front line of the intersect between the government and private sector.
With the domestic industry’s globalization entering a more active phase - the number of Korean biopharma firms advancing into overseas...







